OrganiGram Holdings Inc is seeing a rise in its stock price, reflecting growing investor confidence.
Today, OrganiGram Holdings Inc (OGI.TO) shares are up by 3.76%. This increase comes as the company shows strong growth in its financial performance and expands its market presence.
Investor takeaway: Investors might find OrganiGram's recent performance promising, especially given its significant revenue growth and strategic expansions.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
OrganiGram Holdings Inc
OGI.TO
OGI.TO
OrganiGram Holdings Inc
WealthAwesomeMarket cap
$187.23M
52W high
$3.09
52W low
$1.20
1W change
+3.10%
Beta
1.85
Analyst Price Targets
Based on analyst covering OGI
Wall Street analysts forecast OGI stock price to rise 124.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.98
+124.1% Upside
Current Price
C$1.33
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on OGI's historical volatility
30-Day Vol
47.8%
Annualized
90-Day Vol
54.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.25 | C$1.06 – C$1.48 |
| 60 trading days | C$1.18 | C$0.94 – C$1.49 |
| 90 trading days | C$1.11 | C$0.84 – C$1.48 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
OrganiGram's stock rises by 3.76% today
With a market cap of CA$187.2 million, OrganiGram is establishing itself as a key player in the Canadian cannabis industry.
Bull case
The company has reported a 46% year-over-year increase in gross revenue, reaching CA$97.3 million. This growth indicates a solid operational trajectory. Additionally, expanding into 11 U.S. states could boost its market share and profitability even further.
Bear case
Despite the positive performance, OrganiGram faces challenges, including a negative profit margin of -9.2%. Investors should be cautious about whether this growth can be sustained amid ongoing market volatility.
Strong Financial Performance
Advertisement
OrganiGram's recent financial results show a 46% increase in gross revenue year-over-year, reaching CA$97.3 million. This growth highlights the company's ability to adapt and thrive in a competitive market, making it an appealing option for investors.
Market Expansion Efforts
The company has expanded its U.S. retail presence to 11 states, which could significantly enhance its revenue potential. These strategic moves are crucial for maintaining momentum in the cannabis sector, especially as competition heats up.
Investor Sentiment and Future Outlook
With the stock rising today, investor sentiment seems optimistic. However, potential investors should consider the company's negative profit margin alongside its growth prospects and market conditions before making investment decisions.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
